DISCOVER OUR APPROACH

Restoring the immune system balance with T regulatory cells - Interview with Dr Christie Fanton

Watch

Explore the role of the interleukin-15 (IL-15) pathway in immune response.

Watch

Events

DEC 12

Analyst and Investor Event
Virtual
7:30 Central Time (5:30 AM PT)

Event Registration

NOV 03

Q3’22 Earnings
Virtual
17:00 Eastern Time (2:00 PM PT)

Nektar Earnings Call Registration

AUG 04

Q2’22 Earnings
Virtual
17:00 Eastern Time (2:00 PM PT)

Dial: (833) 634-2591 (U.S); (412) 317-6040 (international)

Listen to Webcast

Latest News

OUR PIPELINE

We are focused on creating novel therapies aimed at selectively modulating the immune system to advance the treatment of cancer, autoimmune disorders and chronic inflammatory conditions.

  • 9

    Million patients benefit from our medicines

    9
    9
    9
  • 12

    Approved products around the world

    12
    12
    12
  • 6

    Clinical development programs

    6
    6
    6

Join Our Team

Find out what it’s like to be part of a dynamic team full of diverse perspectives and unique ideas, brought together by expertise and a passion for making a difference for patients with unmet medical needs.

Read more